← Back to headlines
Pfizer Acquires Rights for Obesity Drug in China for $495M
Pfizer has finalized a deal worth $495 million to secure the rights for an obesity drug in China, expanding its pharmaceutical presence in the region.
24 Feb, 04:34 — 24 Feb, 04:34
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Fuel subsidy to help Iloilo City transport workers amid oil price hikes
just now
Sugar Board favors gov’t buying to prop up prices
just now
Oil: Explosive weekly surge of 35% in US crude and 28% in Brent amid crisis in the Strait of Hormuz
28m ago
US judge allows time for new tariff refund system to be set up
39m ago